Core Viewpoint - The Supervisory Board of Huaron Technology Co., Ltd. convened a meeting to review and approve the 2025 semi-annual report and other significant proposals, ensuring compliance with legal and regulatory requirements [1][2][3] Group 1: Meeting Overview - The 17th meeting of the 5th Supervisory Board was held on August 15, 2025, with all three supervisors present, confirming compliance with relevant laws and regulations [1] - The meeting was chaired by Ms. Hu Zhiwei, the chairperson of the Supervisory Board [1] Group 2: Resolutions Passed - The 2025 semi-annual report and its summary were approved, confirming that the content accurately reflects the company's operational and financial status [1][2] - A proposal to cancel the Supervisory Board, change registered capital, and amend the Articles of Association was approved for submission to the first extraordinary general meeting of shareholders in 2025 [2] - The remuneration for independent directors of the 6th Board was set at 120,000 yuan per person per year (pre-tax), to be paid semi-annually, pending approval at the upcoming shareholders' meeting [2] - A proposal to change the accounting firm was approved for submission to the first extraordinary general meeting of shareholders in 2025 [3] - A proposal to adjust the repurchase price of restricted stock under the 2023 incentive plan and to repurchase and cancel part of the restricted stock was approved [3]

Core Points - The company is holding its second extraordinary general meeting of shareholders in 2025 on September 5, 2025, combining on-site and online voting methods [1][3] - The main agenda includes the proposal to cancel the supervisory board, change registered capital, and amend the company's articles of association [3][4] Proposal Details - The company plans to cancel the supervisory board and transfer its responsibilities to the audit committee of the board of directors, following the latest legal and regulatory requirements [4][3] - The number of directors will increase from 7 to 8, with the addition of a worker representative director elected by the employee representative assembly [4][3] - The registered capital will be adjusted due to the cancellation of stock options for 110 individuals, resulting in a reduction of total shares from 476,900,681 to 475,726,781 [4][5] - Amendments to the articles of association will reflect the cancellation of the supervisory board and changes in registered capital, including the removal of references to the supervisory board and its members [4][5] Meeting Procedures - The meeting will require attendees to present identification and proof of shareholding to participate [1][3] - The company reserves the right to refuse entry to unauthorized individuals to maintain order during the meeting [1][3] - Voting will occur both in-person and online, with specific timeframes for each method [1][3]

Meeting Overview - The third meeting of the third Supervisory Board of Shenzhen Guangfeng Technology Co., Ltd. was held on August 28, 2025, with all three members present, and the meeting was deemed legally valid [1]. Financial Reports - The Supervisory Board approved the 2025 Half-Year Report and its summary, confirming that the report accurately reflects the company's financial status and operational results for the first half of 2025 [1][2]. - The board also approved the Special Report on the Storage and Use of Raised Funds for the first half of 2025, affirming compliance with relevant regulations and confirming that the use of funds aligns with previously disclosed information [2]. Governance Changes - The board approved a proposal to abolish the Supervisory Board and amend the company's Articles of Association, transferring the supervisory responsibilities to the Audit Committee of the Board [2][3]. - This decision aims to enhance the corporate governance structure in line with the latest legal requirements and the company's operational needs [3]. Stock Incentive Plans - The board approved adjustments to the grant price of the restricted stock incentive plan, ensuring compliance with relevant regulations and protecting shareholder interests [4]. - A proposal to void certain unvested restricted stocks from the 2022 incentive plan was also approved, affecting those who no longer qualify as incentive recipients [5]. - The board confirmed that the conditions for the second vesting period of the 2022 restricted stock incentive plan have been met, allowing for the registration of 33,290 shares for five eligible recipients [6]. - Additionally, the board approved the voiding of unvested stocks from the 2021 second phase incentive plan, totaling 414,000 shares, due to non-qualification of certain recipients [8]. Fund Management - The board approved the permanent allocation of remaining excess funds from the initial public offering project to supplement working capital, which is expected to enhance the efficiency of fund utilization [9][10].

Core Viewpoint - The legal opinion letter from King & Wood Mallesons (Beijing) confirms that Shandong Dongyue Silicon Materials Co., Ltd. has complied with necessary legal requirements for the adjustment of its 2024 restricted stock incentive plan, including the approval and authorization processes [5][8]. Group 1: Legal Framework and Compliance - The legal opinion is based on various laws and regulations, including the Company Law, Securities Law, and relevant guidelines from the China Securities Regulatory Commission [1][2]. - The adjustment of the incentive plan is in accordance with the previously effective regulations and the company's articles of association [2][4]. - King & Wood Mallesons has verified the authenticity and completeness of the documents provided by the company, ensuring that there are no significant omissions or misrepresentations [3][4]. Group 2: Approval and Authorization - On October 29, 2024, the company held its second extraordinary general meeting to approve the authorization for the board of directors to handle matters related to the stock incentive plan [5][6]. - The board's remuneration and assessment committee approved the adjustment of the grant price for the restricted stock on August 25, 2025, with relevant members recusing themselves from the vote [6]. - The supervisory board also approved the adjustment on the same date, confirming that necessary approvals have been obtained [6][8]. Group 3: Adjustment Details - The adjustment of the grant price for the restricted stock is due to the completion of the company's profit distribution for the 2024 fiscal year, which included a cash dividend of 0.15 yuan per share, totaling 18 million yuan [7]. - The adjustment formula for the grant price is specified, ensuring that the adjusted price remains above 1 yuan per share [7]. - Following the adjustment, the grant price for the restricted stock has been revised from 5.90 yuan per share to 5.885 yuan per share [7][8]. Group 4: Conclusion - King & Wood Mallesons concludes that the company has fulfilled the necessary approvals and that the adjustment complies with relevant regulations and the incentive plan [8].

Group 1 - The board of directors of the company held its 11th meeting of the 4th session on August 19, 2025, with all 6 directors present, confirming the meeting's legality and compliance with relevant laws and regulations [1] - The board approved the use of up to 400 million yuan of idle raised funds for cash management, which can be used in a rolling manner within a twelve-month period from the date of approval [1] - The company announced a plan to distribute equity to shareholders, with a stock dividend of 4.5 shares for every 10 shares held, based on a total share capital of 680,152,346 shares, excluding repurchased shares [2] Group 2 - The company adjusted the number and price of restricted stock grants under its 2022 incentive plan, increasing the reserved grant quantity from 306,000 shares to 443,700 shares and reducing the grant price from 5.55 yuan per share to 3.83 yuan per share [2] - Due to the departure of two incentive targets, a total of 143,550 shares of restricted stock will be canceled and treated as void [3] - The board confirmed that the conditions for the third vesting period of the reserved grant portion of the 2022 incentive plan have been met, allowing the company to proceed with the relevant matters [3]

Group 1 - The company held its 19th meeting of the second Supervisory Board on August 5, 2025, with all three supervisors present, including one participating via remote voting [1][2] - The Supervisory Board approved a proposal to adjust the company's governance structure and amend relevant provisions in the Articles of Association to enhance operational standards and governance [1][2] - The proposal requires approval from the company's second extraordinary general meeting of shareholders in 2025, needing more than two-thirds of the voting rights held by attending shareholders [2] Group 2 - The Supervisory Board agreed to adjust the 2023 Restricted Stock Incentive Plan, confirming that the adjustments comply with relevant regulations and do not harm shareholder interests [2] - The Board approved the vesting of 9,663 shares of restricted stock for 10 eligible incentive recipients, as the conditions for the first vesting period have been met [2][3]

Core Viewpoint - The legal opinion letter issued by Guangdong Xinda Law Firm confirms that the adjustments to the 2023 and 2025 restricted stock incentive plans of Xianle Health Technology Co., Ltd. have obtained the necessary approvals and comply with relevant laws and regulations [1][14][20]. Group 1: 2023 Restricted Stock Incentive Plan - The 2023 incentive plan has undergone adjustments due to the company's capital reserve conversion and stock dividend distribution, affecting the repurchase price and quantity of restricted stocks [14][15]. - The initial grant price for the restricted stocks was adjusted from 9.78 yuan to 7.52 yuan per share, and the total number of restricted stocks granted was adjusted to 1,343,888 shares [15][16][20]. - The company has completed the registration of 1,094,275 shares for the initial grant and 249,613 shares for the reserved grant, with the listing date set for December 27, 2023 [7][9]. Group 2: 2025 Restricted Stock Incentive Plan - The 2025 incentive plan has also been adjusted, with the initial grant price set at 13.27 yuan per share, which was later adjusted to 10.21 yuan per share due to similar corporate actions [19][20]. - The total number of restricted stocks for the initial grant was adjusted to 1,821,300 shares, reflecting the company's capital reserve conversion and stock dividend distribution [20]. - The company has confirmed that the proposed recipients of the 2025 incentive plan meet all legal and regulatory requirements, with no objections raised during the public disclosure period [12][13].

Group 1 - The company held its third meeting of the sixth board of directors on June 23, 2025, via telecommunication voting, with all five directors present [1] - The meeting was convened and chaired by Chairman Su Wuhong, and it complied with relevant laws and regulations [1] - The board approved a proposal to adjust the business scope and amend the company's articles of association, which will require registration with the industrial and commercial authorities [1][2] Group 2 - The company announced a cash dividend distribution plan for the 2024 fiscal year, amounting to RMB 0.2 per share, totaling RMB 2,186,763.18, with no stock dividends or capital reserves being converted into share capital [3] - The board adjusted the grant price and repurchase price of the second category of restricted stock under the 2023 Restricted Stock Incentive Plan [3] - The repurchase price for the first category of restricted stock was adjusted to RMB 8.52 per share due to performance issues and employee departures [3][4] Group 3 - The company plans to hold its first extraordinary general meeting of shareholders on July 9, 2025 [4] - The board's proposals received unanimous approval with no votes against or abstentions [4][5]

Group 1 - The company held its 11th meeting of the 5th Supervisory Board on June 20, 2025, with all three supervisors present, including two via remote voting [1] - The Supervisory Board approved the proposal to postpone certain fundraising projects with a unanimous vote, stating that the postponement does not change the purpose or direction of the raised funds and will not materially affect the company's operations [1][2] - The board also reviewed a proposal to amend the remuneration management measures for directors, supervisors, and senior management, with all supervisors abstaining from the vote, which will be submitted to the shareholders' meeting for approval [2][3] Group 2 - The Supervisory Board approved adjustments to the repurchase price of the 2024 restricted stock incentive plan with a majority vote, confirming that the adjustments comply with relevant regulations and do not harm shareholder interests [2][3]

Group 1 - The legal opinion letter is issued by Grandall Law Firm (Shanghai) regarding the adjustment of the grant price for the 2021 restricted stock incentive plan of Lekai Ergonomics Technology Co., Ltd. [1][2] - The adjustment of the grant price is based on the company's compliance with relevant laws, regulations, and its own articles of association [2][11] - The company has obtained necessary approvals from the board of directors, supervisory board, and shareholders' meeting for the incentive plan [6][9] Group 2 - The grant price for the restricted stock has been adjusted from 11.06 yuan per share to 8.24 yuan per share due to the implementation of the 2022 annual equity distribution plan [7][9] - The adjustment method for the grant price follows the provisions of the incentive plan, which includes considerations for cash dividends and other corporate actions [10][11] - The company is required to fulfill its information disclosure obligations as per relevant laws and regulations following the adjustment [12]